PAGANI, LISA
 Distribuzione geografica
Continente #
AS - Asia 2.499
EU - Europa 2.121
NA - Nord America 1.898
SA - Sud America 346
AF - Africa 42
OC - Oceania 11
Totale 6.917
Nazione #
US - Stati Uniti d'America 1.810
IT - Italia 858
SG - Singapore 827
VN - Vietnam 559
CN - Cina 504
RU - Federazione Russa 326
HK - Hong Kong 303
BR - Brasile 290
DE - Germania 273
IE - Irlanda 150
SE - Svezia 105
GB - Regno Unito 90
FR - Francia 73
KR - Corea 65
NL - Olanda 53
ID - Indonesia 50
IN - India 49
CA - Canada 48
FI - Finlandia 43
AT - Austria 40
ES - Italia 31
JP - Giappone 27
ZA - Sudafrica 26
MX - Messico 24
PL - Polonia 22
AR - Argentina 20
IR - Iran 17
TR - Turchia 16
BD - Bangladesh 15
EC - Ecuador 14
SA - Arabia Saudita 13
AU - Australia 11
LT - Lituania 10
TW - Taiwan 10
BE - Belgio 9
IQ - Iraq 8
UZ - Uzbekistan 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
CO - Colombia 6
VE - Venezuela 6
UA - Ucraina 5
PH - Filippine 4
PK - Pakistan 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
PT - Portogallo 3
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
HN - Honduras 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 6.917
Città #
Singapore 519
Ashburn 378
Milan 303
Hong Kong 301
Ho Chi Minh City 188
Dallas 165
Frankfurt am Main 159
Hanoi 154
Dublin 148
Hefei 148
New York 102
Los Angeles 90
Ann Arbor 85
Chandler 85
Santa Clara 85
Beijing 67
Seoul 58
Munich 50
Shanghai 42
São Paulo 36
Jakarta 35
Buffalo 30
Moscow 29
Chicago 27
Kent 27
Nuremberg 27
Florence 24
The Dalles 24
London 21
Boston 20
Da Nang 20
Denver 20
Rome 20
Brooklyn 19
Tokyo 19
Turku 19
Montreal 18
Orem 18
Haiphong 16
Helsinki 16
Hải Dương 16
Johannesburg 16
Madison 16
Warsaw 16
Amsterdam 14
Genoa 14
Vienna 14
Cinisello Balsamo 13
Ha Long 13
Ripalta Cremasca 13
Biên Hòa 12
Can Tho 12
Naples 12
Poplar 12
Seregno 12
Stockholm 12
Toronto 12
Cagliari 11
Chennai 11
Como 11
Romola 11
Bergamo 10
Monza 10
Ninh Bình 10
Phoenix 10
Quận Bình Thạnh 10
Brussels 9
Carate Brianza 9
Melzo 9
Mexico City 9
Pune 9
Rio de Janeiro 9
Sesto San Giovanni 9
Ankara 8
Düsseldorf 8
Princeton 8
Riyadh 8
San Jose 8
Tashkent 8
Terni 8
Vercelli 8
Atlanta 7
Caronno Pertusella 7
Coventry 7
Minamikasugaoka 7
Paris 7
Segrate 7
Thái Nguyên 7
Turin 7
A Coruña 6
Bắc Ninh 6
Cape Town 6
Guayaquil 6
Hangzhou 6
Houston 6
Kelty 6
Lappeenranta 6
Lauterbourg 6
Manchester 6
Messina 6
Totale 4.184
Nome #
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 498
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 303
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 299
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 277
A molecular imaging approach to individuate tumour infiltrating lymphocytes 249
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 240
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 240
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 227
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 227
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 227
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 224
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 218
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 211
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 209
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 205
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 202
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 202
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 200
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 194
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 192
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 192
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 185
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 177
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 170
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 167
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 143
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 133
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 132
Tailored proteomic approaches based on nano-Liquid Chromatography-Mass Spectrometry to address biomedical challenging issues 128
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 127
Proteomic and glycoproteomic approaches based on nLC-ESI MS/MS for exploring cancer matrisome: explorative study 123
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 120
Proteomic characterization and comparison of human platelet lysates for a standardized and high quality production 110
Proteomic monitoring by label-free nLC-MS/MS of human platelet lysates for a standardized and optimized production 104
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 85
Deep proteome investigation in clinical studies: from the method development to its application 81
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 20
Totale 7.041
Categoria #
all - tutte 23.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 8 30 21 19 0 9 7 7 24 30
2022/2023596 68 84 61 87 38 74 23 35 37 19 30 40
2023/2024733 19 22 27 84 64 188 114 39 50 16 35 75
2024/20252.259 72 169 142 111 218 106 158 72 234 387 215 375
2025/20263.298 958 396 492 699 457 295 1 0 0 0 0 0
Totale 7.041